Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

PaperCitations, authors & open-access status

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 535 citations, 2020 year and green oa status.

535
Citations
2020
Year
green
OA Status

Related on ScholarIQ

David C. Wheeler
Author
Robert D. Toto
Author
Tom Greene
Author
Niels Jongs
Author
John J.V. McMurray
Author
Glenn M. Chertow
Author
470M+ articles · free account